The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence

被引:152
作者
Banks, DJ [1 ]
Beres, SB [1 ]
Musser, JM [1 ]
机构
[1] NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA
关键词
D O I
10.1016/S0966-842X(02)02461-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human bacterial pathogen group A Streptococcus (GAS) causes many different diseases including pharyngitis, tonsillitis, impetigo, scarlet fever, streptococcal toxic shock syndrome, necrotizing fasciitis and myositis, and the post-infection sequelae glomerulonephritis and rheumatic fever. The frequency and severity of GAS infections increased in the 1980s and 1990s, but the cause of this increase is unknown. Recently, genome sequencing of serotype M1, M3 and M 18 strains revealed many new proven or putative virulence factors that are encoded by phages or phage-like elements. Importantly, these genetic elements account for an unexpectedly large proportion of the difference in gene content between the three strains. These new genome-sequencing studies have provided evidence that temporally and geographically distinct epidemics, and the complex array of GAS clinical presentations, might be related in part to the acquisition or evolution of phage-encoded virulence factors. We anticipate that new phage-encoded virulence factors will be identified by sequencing the genomes of additional GAS strains, including organisms non-randomly associated with particular clinical syndromes.
引用
收藏
页码:515 / 521
页数:7
相关论文
共 54 条
[41]   Epidemiology of invasive group A Streptococcus disease in the United States, 1995-1999 [J].
O'Brien, KL ;
Beall, B ;
Barrett, NL ;
Cieslak, PR ;
Reingold, A ;
Farley, MM ;
Danila, R ;
Zell, ER ;
Facklam, R ;
Schwartz, B ;
Schuchat, A .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (03) :268-276
[42]   Diversification of Escherichia coli genomes:: are bacteriophages the major contributors? [J].
Ohnishi, M ;
Kurokawa, K ;
Hayashi, T .
TRENDS IN MICROBIOLOGY, 2001, 9 (10) :481-485
[43]   Identification and characterization of novel superantigens from Streptococcus pyogenes [J].
Proft, T ;
Moffatt, SL ;
Berkahn, CJ ;
Fraser, JD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (01) :89-101
[44]   CHANGING EPIDEMIOLOGY OF GROUP-A STREPTOCOCCAL INFECTION IN THE USA [J].
SCHWARTZ, B ;
FACKLAM, RR ;
BREIMAN, RF .
LANCET, 1990, 336 (8724) :1167-1171
[45]   RESISTANCE TO ERYTHROMYCIN IN GROUP-A STREPTOCOCCI [J].
SEPPALA, H ;
NISSINEN, A ;
JARVINEN, H ;
HUOVINEN, S ;
HENRIKSSON, T ;
HERVA, E ;
HOLM, SE ;
JAHKOLA, M ;
KATILA, ML ;
KLAUKKA, T ;
KONTIAINEN, S ;
LIIMATAINEN, O ;
OINONEN, S ;
PASSIMETSOMAA, L ;
HUOVINEN, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (05) :292-297
[46]   Severe group A streptococcal soft-tissue infections in Ontario: 1992-1996 [J].
Sharkawy, A ;
Low, DE ;
Saginur, R ;
Gregson, D ;
Schwartz, B ;
Jessamine, P ;
Green, K ;
McGeer, A .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (04) :454-460
[47]   Molecular analysis of group A Streptococcus type emm18 isolates temporally associated with acute rheumatic fever outbreaks in Salt Lake City, Utah [J].
Smoot, JC ;
Korgenski, EK ;
Daly, JA ;
Veasy, LG ;
Musser, JM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (05) :1805-1810
[48]   Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks [J].
Smoot, JC ;
Barbian, KD ;
Van Gompel, JJ ;
Smoot, LM ;
Chaussee, MS ;
Sylva, GL ;
Sturdevant, DE ;
Ricklefs, SM ;
Porcella, SF ;
Parkins, LD ;
Beres, SB ;
Campbell, DS ;
Smith, TM ;
Zhang, Q ;
Kapur, V ;
Daly, JA ;
Veasy, LG ;
Musser, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (07) :4668-4673
[49]   Global differential gene expression in response to growth temperature alteration in group A Streptococcus [J].
Smoot, LM ;
Smoot, JC ;
Graham, MR ;
Somerville, GA ;
Sturdevant, DE ;
Migliaccio, CAL ;
Sylva, GL ;
Musser, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10416-10421
[50]   Mitogenic factor (MF) is the major DNase of serotype M89 Streptococcus pyogenes [J].
Sriskandan, S ;
Unnikrishnan, M ;
Krausz, T ;
Cohen, J .
MICROBIOLOGY-SGM, 2000, 146 :2785-2792